SAFE HARBORThis release may contain forward – looking statements within the meaning of the federal securities laws. Such forward-looking statements are made, and including the current expectations, plans and strategies, and anticipated financial results, subject to known and subject to known and unknown risks, uncertainties and factors that cause our actual results to differ materially from those by identify these statements implied. Many of these risks are beyond our ability to control or predict check this web-site . See ‘Risk Factors ‘under ‘Item 6 Management Discussion and Analysis of Financial Condition and Results of Operation’from our Annual Report on Form 10 – KSB for the year ended 31 December 2005, and other descriptions in the company’s history, public filings with the Securities and Exchange Commission a discussion a discussion of these risks, including the company’s need for additional funding, the Company’s dependence on a limited number of therapeutic compounds, the stage of company’s products, the development, uncertainties related to clinical trials and regulatory reviews, competition and dependence on collaborative partners, avoid the company’s ability to infringe the patent rights of others, and the Company’s ability to obtain adequate patent protection and these rights these rights. Given these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. In addition, forward-looking statements speak only as of the date they are made. Avicena assumes no obligation to update or review any such forward-looking statements, whether as a result of new information, future events or otherwise. Avicena Group.
For colorectal cancer screening of was to commence aged between 50 for men with an average risk. Those who need with certain risk factors screening of begin earlier.
Cancer is the second greatest cancer killer in men and women, second only to cancer. A few 148,810 American diagnosed of colorectal carcinoma this year, 960 human die of the disease.